Oral anti-tuberculosis drugs: An urgent medication reconciliation at hospitals in Indonesia

Background: Four oral anti-tuberculosis drugs are conceived to be the most effective ones eradicate Mycobacterium tuberculosis bacteria and obviate resistant organisms. However, patients' adherence medication discrepancies obstacles achieving goal. This study aimed define used in hospitals detect continuity of treatment.Design Methods: retrospective cross-sectional was based on medical records adult patients, conducted two district tertiary care hospitals. Only 35 out 136 patient from Hospital A 33 85 B met inclusion criteria.Results: The common systemic anti-infective were ceftriaxone (51.80 DDD/100 patient-days) isoniazid (59.53 B. number rifampicin prescriptions less than that isoniazid. Each received an average patient-days, which is under dosage for treatment.Conclusion: showed a discrepancy Tuberculosis therapy. patients’ histories not full attention treating physicians wherever they admitted. Thus, reconciliation needed accomplish goal Tuberculosis-free world 2050.